Business Description
BIMI International Medical Inc
NAICS : 325412
SIC : 5912
ISIN : US6290993004
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | -0.41 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | -3 | |||||
Beneish M-Score | -3.35 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 10.4 | |||||
3-Year EPS without NRI Growth Rate | 11.4 | |||||
3-Year FCF Growth Rate | 32.8 | |||||
3-Year Book Growth Rate | -71.8 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.21 | |||||
Quick Ratio | 0.86 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 306.04 | |||||
Days Sales Outstanding | 142.8 | |||||
Days Payable | 437.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -174.8 | |||||
Shareholder Yield % | 42.7 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.3 | |||||
Operating Margin % | -30.82 | |||||
Net Margin % | -96.45 | |||||
FCF Margin % | -23.34 | |||||
ROE % | -148.42 | |||||
ROA % | -34.48 | |||||
ROIC % | -18.62 | |||||
ROC (Joel Greenblatt) % | -137.44 | |||||
ROCE % | -79.28 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.43 | |||||
PB Ratio | 0.91 | |||||
Price-to-Tangible-Book | 1.28 | |||||
EV-to-EBIT | -1.81 | |||||
EV-to-EBITDA | -1.85 | |||||
EV-to-Revenue | 1.59 | |||||
EV-to-FCF | -6.94 | |||||
Earnings Yield (Greenblatt) % | -55.25 | |||||
FCF Yield % | -17.4 | |||||
Forward Rate of Return (Yacktman) % | -910.25 |